Medical Topical Hemostatic Agent Market, Global Outlook and Forecast 2023-2029

Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
This report aims to provide a comprehensive presentation of the global market for Medical Topical Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Topical Hemostatic Agent. This report contains market size and forecasts of Medical Topical Hemostatic Agent in global, including the following market information:
Global Medical Topical Hemostatic Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Topical Hemostatic Agent Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Medical Topical Hemostatic Agent companies in 2022 (%)
The global Medical Topical Hemostatic Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Gelation Sponge Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Topical Hemostatic Agent include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences and B Braun Melsungen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Topical Hemostatic Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Topical Hemostatic Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, by Type, 2022 (%)
    Gelation Sponge
    Oxidized Regenerated Cellulose Based Hemostats
    Others
Global Medical Topical Hemostatic Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Surgical Centers
    Nursing Homes
Global Medical Topical Hemostatic Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Topical Hemostatic Agent Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Topical Hemostatic Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Topical Hemostatic Agent revenues share in global market, 2022 (%)
Key companies Medical Topical Hemostatic Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Topical Hemostatic Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Ethicon
    Pfizer
    Baxter International
    C. R. Bard
    The Medicines Company
    Anika Therapeutics
    Advanced Medical Solutions
    Integra LifeSciences
    B Braun Melsungen
    Gelita Medical
    Equimedical
    Vascular Solutions
    Marine Polymer Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Topical Hemostatic Agent, market overview.
Chapter 2: Global Medical Topical Hemostatic Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Topical Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Topical Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Topical Hemostatic Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.